Coral Laboratories Ltd

Coral Labs. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Coral Laboratories Ltd

₹ 600 0.75%
13 Jun - close price
corallab.com BSE: 524506
About

Incorporated in 1994, Coral Laboratories Ltd is in the business of pharmaceutical formulations[1]

Key Points

Business Overview:[1]
CLL is an ISO 9001:2008 certified manufacturer and exporter of pharmaceutical formulations like tablets, capsules, liquid, and topical preparations. It focuses on generics, troubleshooting existing products, and patent noninfringing products for emerging markets.

Website BSE
  • Market Cap ₹ 214 Cr.
  • Current Price ₹ 600
  • High / Low ₹ 999 / 571
  • Stock P/E 8.66
  • Book Value ₹ 563
  • Dividend Yield 0.33 %
  • ROCE 17.4 %
  • ROE 13.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 1.07 times its book value
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 28.2% CAGR over last 5 years

Cons

  • Company has a low return on equity of 9.21% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
20.08 16.25 25.70 24.73 11.44 13.55 23.15 18.08 28.89 31.66 32.23 22.99 28.13
19.03 15.52 21.39 23.88 13.52 11.81 17.00 15.98 22.64 20.92 25.72 16.67 25.44
Operating Profit 1.05 0.73 4.31 0.85 -2.08 1.74 6.15 2.10 6.25 10.74 6.51 6.32 2.69
OPM % 5.23% 4.49% 16.77% 3.44% -18.18% 12.84% 26.57% 11.62% 21.63% 33.92% 20.20% 27.49% 9.56%
2.49 2.03 2.21 1.54 1.16 1.29 1.81 1.37 2.00 1.56 2.54 2.52 1.71
Interest 0.05 0.10 0.11 0.11 0.02 0.00 0.00 0.00 0.00 0.03 0.01 0.02 0.04
Depreciation 0.50 0.50 0.50 0.50 0.68 0.55 0.44 0.49 0.50 0.49 0.51 0.50 0.51
Profit before tax 2.99 2.16 5.91 1.78 -1.62 2.48 7.52 2.98 7.75 11.78 8.53 8.32 3.85
Tax % 14.72% 26.39% 17.26% 51.69% -45.06% 26.21% 20.21% 27.52% 25.16% 25.21% 25.21% 26.08% 26.49%
2.55 1.59 4.89 0.86 -0.89 1.84 6.00 2.16 5.79 8.80 6.38 6.14 2.83
EPS in Rs 7.14 4.45 13.69 2.41 -2.49 5.15 16.79 6.05 16.21 24.63 17.86 17.19 7.92
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
51 59 77 95 92 91 71 97 76 78 84 115
41 47 60 72 77 79 65 81 67 74 67 89
Operating Profit 10 12 16 23 15 12 5 16 8 4 16 26
OPM % 20% 21% 21% 24% 17% 14% 8% 16% 11% 5% 19% 23%
1 3 3 3 4 5 6 4 6 7 6 8
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 1 3 2 2 2 2 2 2 2 2 2 2
Profit before tax 10 12 17 25 18 16 9 18 12 8 21 32
Tax % 21% 22% 29% 34% 31% 34% 22% 23% 24% 22% 24% 26%
8 10 12 16 12 10 7 14 9 6 16 24
EPS in Rs 22.03 26.79 34.71 45.63 34.85 28.61 19.96 37.93 25.33 18.05 44.20 67.63
Dividend Payout % 9% 9% 9% 11% 6% 7% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 7%
5 Years: 10%
3 Years: 15%
TTM: 37%
Compounded Profit Growth
10 Years: 10%
5 Years: 28%
3 Years: 44%
TTM: 55%
Stock Price CAGR
10 Years: 5%
5 Years: 27%
3 Years: 34%
1 Year: 5%
Return on Equity
10 Years: 10%
5 Years: 9%
3 Years: 9%
Last Year: 13%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 4 4 4 4 4 4 4 4 4 4 4 4
Reserves 47 56 67 106 113 110 112 133 152 151 174 198
0 1 0 2 2 1 6 6 6 0 0 4
10 12 19 20 22 21 23 25 28 20 28 25
Total Liabilities 60 72 89 131 140 136 144 168 190 174 206 229
20 19 18 18 22 23 23 21 24 25 24 23
CWIP 0 0 0 0 0 0 0 0 2 0 0 2
Investments 1 1 5 39 45 28 25 33 46 41 50 52
40 52 67 74 73 84 97 112 118 108 132 152
Total Assets 60 72 89 131 140 136 144 168 190 174 206 229

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1 0 5 11 13 -1 -4 1 6 13 -5 -1
1 -0 -3 -10 -13 3 -2 -0 -6 -3 1 -0
0 -0 -0 0 -3 -1 4 0 0 -6 0 3
Net Cash Flow 2 -0 2 1 -2 1 -2 1 0 4 -4 1

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 109 152 132 117 125 122 178 148 184 109 123 107
Inventory Days 97 110 110 155 120 116 176 158 169 100 149 68
Days Payable 61 66 80 75 87 91 129 108 81 34 130 46
Cash Conversion Cycle 145 196 162 197 157 146 225 198 272 176 142 129
Working Capital Days 159 202 181 172 168 177 241 202 251 221 183 239
ROCE % 21% 22% 27% 28% 16% 13% 8% 13% 7% 5% 13% 17%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
71.51% 71.51% 71.51% 71.51% 71.51% 71.51% 71.51% 71.51% 71.51% 71.51% 71.51% 71.51%
0.42% 0.14% 0.14% 0.14% 0.14% 0.14% 0.14% 0.14% 0.23% 0.00% 0.00% 0.00%
28.07% 28.34% 28.34% 28.34% 28.35% 28.34% 28.35% 28.35% 28.26% 28.50% 28.49% 28.49%
No. of Shareholders 4,3174,2184,1104,0464,0403,9814,0054,0983,8313,9494,0544,105

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports